hek293 human embryonic kidney derived cells (ATCC)
Structured Review

Hek293 Human Embryonic Kidney Derived Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 21992 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+embryonic+kidney+derived+hek293/pmc11063024-161-0-8?v=ATCC
Average 99 stars, based on 21992 article reviews
Images
1) Product Images from "Novel loading protocol combines highly efficient encapsulation of exogenous therapeutic toxin with preservation of extracellular vesicles properties, uptake and cargo activity"
Article Title: Novel loading protocol combines highly efficient encapsulation of exogenous therapeutic toxin with preservation of extracellular vesicles properties, uptake and cargo activity
Journal: Discover Nano
doi: 10.1186/s11671-024-04022-8
Figure Legend Snippet: Evaluation of structural modifications of nsEVs after sodium carbonate treatment. Transmission electron microscopy (TEM) image ( A ) and nanoparticle tracking analysis ( B ) of HEK293-derived nsEVs after sodium carbonate treatment. Western blot analysis ( C ) of Alix, TSG101, CD63 and CD9 before (pre) and after (post) sodium carbonate treatment. Comparison of nsEVs treated with phosphate buffer saline (PBS) or sodium carbonate (Na 2 CO 3 ) through silver staining ( D ) single-particle interferometric reflectance imaging sensor (SP-IRIS) analysis (E) and Raman spectroscopy (F). M: molecular weight marker
Techniques Used: Transmission Assay, Electron Microscopy, Derivative Assay, Western Blot, Comparison, Saline, Silver Staining, Single Particle, Imaging, Raman Spectroscopy, Molecular Weight, Marker
Figure Legend Snippet: Encapsulation efficiency evaluation and comparison between electroporation and sodium carbonate treatment. A Spectrofluorometer analysis for quantification of Dextran-FITC incorporation after 50 V electroporation (see material and methods) or sodium carbonate treatment of HEK293-derived nsEVs (25 µg/ml) in various nsEVs:Dextran-FITC ratios (1:1, 1:1.5 and 1:2). B Confocal microscopy images of Hela cells treated for 24 h with Dextran-FITC bearing nsEVs (25 µg/ml) after electroporation (50 V) or sodium carbonate incubation in NsEVs:Dextran-FITC = 1:1.5 molecular ratio (blue = DAPI; green = Dextran-FITC bearing nsEVs). C Spectrofluorometer analysis for quantification of SAP-FITC incorporation after 50 V electroporation (see material and methods) or sodium carbonate treatment of HEK293-derived nsEVs (25 µg/ml) in nsEVs:SAP-FITC = 1:1.5 ratio
Techniques Used: Encapsulation, Comparison, Electroporation, Derivative Assay, Confocal Microscopy, Incubation
Figure Legend Snippet: Evaluation of sodium carbonate-treated SAP-bearing nsEVs uptake. A Bright field (upper row) and fluorescent (lower row) microscopy images of 5637 cells 24 h after incubation with HEK293-derived nsEVs treated with phosphate buffer saline (PBS, left) or sodium carbonate (Na 2 CO 3 , right) in the presence of SAP and stained with Vybrant Dio lipophilic dye. Different concentrations of nsEVs (5 and 10 µg) were used for comparison. Representative images of three independent experiments. B Flow cytometry analysis of 5637 cells 24 h after treatment with 5 or 10 µg of PBS or Na 2 CO 3 -treated SAP-bearing nsEVs. Results are shown as mean fluorescence percentage + SD from 3 independent experiments
Techniques Used: Microscopy, Incubation, Derivative Assay, Saline, Staining, Comparison, Flow Cytometry, Fluorescence

